NASDAQ:PEPT REX Peptide ETF (PEPT) Price, Holdings, & News $27.71 -0.11 (-0.40%) As of 02:16 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldings About REX Peptide ETF (NASDAQ:PEPT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get REX Peptide ETF alerts:Sign Up Key Stats Today's Range$27.68▼$27.8750-Day Range N/A52-Week Range$25.06▼$28.14Volume5,029 shsAverage Volume7,117 shsMarket Capitalization$3.33 millionAssets Under Management$3.32 millionDividend YieldN/ANet Expense Ratio0.65%Aggregate RatingN/A ETF Overview REX Peptide ETF (NASDAQ: PEPT) is an exchange-traded fund designed to provide targeted exposure to companies involved in the development, production, and commercialization of peptide-based medicines and related technologies. Rather than operating as a traditional company, the fund holds a portfolio of businesses participating in the broader peptide therapeutics industry. The fund’s investment focus may include pharmaceutical and biotechnology companies developing peptide treatments, as well as businesses supporting peptide research, drug discovery, manufacturing, delivery systems, and related healthcare applications. Peptide-based therapies are used or studied across areas such as metabolic disorders, obesity, diabetes, oncology, and other chronic or specialized medical conditions. PEPT is sponsored by REX Shares, an investment-management platform offering exchange-traded products. The ETF is listed on Nasdaq and is intended for investors seeking focused exposure to the peptide medicine ecosystem through a single publicly traded fund rather than selecting individual companies.AI Generated. May Contain Errors. Read More REX Peptide ETF ExpensesTypePEPTTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.65%0.57%0.57%0.54%0.53%Other Expenses0.00%0.57%0.53%0.38%0.54%Total Expense0.65%0.72%0.75%0.69%0.73%Fee Waiver0.00%-0.72%-0.67%-0.41%-0.67%Net Expense0.65%0.60%0.63%0.61%0.60% Receive PEPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for REX Peptide ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PEPT ETF News HeadlinesGLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?Compares the Roundhill GLP-1 & Weight Loss ETF (OZEM) and the newer REX Peptide ETF (PEPT), examining holdings, fees, and overlap as GLP-1 drug demand from Eli Lilly and Novo Nordisk continues to grow.November 2, 2026 | marketbeat.comSee More Headlines PEPT ETF - Frequently Asked Questions How have PEPT shares performed this year? REX Peptide ETF's stock was trading at $27.01 on October 30, 2026. Since then, PEPT shares have increased by 2.6% and is now trading at $27.71. How do I buy shares of REX Peptide ETF? Shares of PEPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerREX Advisers Fund NameREX Peptide ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:PEPT Inception Date10/12/2026 Fund ManagerMatthew Pelletier, Matthew Holcomb Webwww.rexshares.com Phone(203) 654-7008Fund Focus Asset ClassEquity BenchmarkVettaFi Peptide Index CategoryStrategy FocusTheme Development LevelDeveloped Markets RegionGlobal Number of Holdings35 Fund Statistics Assets Under Management$3.32 million Average Daily Volume$0.00 Discount/Premium0.12% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorREX Advisers, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerOld Mission Miscellaneous Outstanding Shares120,000BetaN/A 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report PEPT Sector ExposurePEPT Industry Exposure This page (NASDAQ:PEPT) was last updated on 11/10/2026 by MarketBeat.com Staff. From Our PartnersBlack Friday Bombshell (for traders)For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTwo charts tell you the future…Gold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...Golden Portfolio | SponsoredIt’s now or neverAnthropic's Claude now generates more revenue than ChatGPT, and the company is about to go public at a $1.5 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding REX Peptide ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share REX Peptide ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PEPT Stock Alerts